In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $6.9bn, according to GlobalData’s Deals Database. The $6.9bn acquisition of Viatris by Cooper Consumer Health and IQuest Enterprises was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in Italy increased by 1185% in Q4 2023 compared with the previous quarter’s total of $537m and rose by 3145% as compared to Q4 2022. Related deal volume increased by 133% in Q4 2023 versus the previous quarter and was 22% lower than in Q4 2022.
The top-ranked financial advisors supporting these M&A deals in Italy in Q4 2023 were Banca Profilo; BDA Partners; Cross Border with 1, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these M&A deals in Italy Q4 2023 were Dentons UK and Middle East; Jones Day; Clifford Chance with 2, 2, 1 deals respectively.
See Also:
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.